Treatment Options for Headaches in Patients Who Cannot Take NSAIDs
For patients who cannot take NSAIDs, acetaminophen (1000 mg) is the recommended first-line treatment for mild to moderate headaches, while triptans (such as sumatriptan) are recommended for moderate to severe migraines in patients without contraindications. 1, 2
Acute Treatment Options
First-Line Options
Acetaminophen (1000 mg)
Acetaminophen-caffeine combinations
- Can provide enhanced efficacy compared to acetaminophen alone 1
Second-Line Options (for moderate to severe headaches)
Triptans (e.g., sumatriptan)
Metoclopramide (10 mg)
Preventive Treatment Options for Recurrent Headaches
For patients with frequent headaches who cannot take NSAIDs, several preventive options are available:
Beta-blockers
- Propranolol (80-240 mg/day) or timolol (20-30 mg/day) 1
- Caution: Use carefully in patients with asthma, diabetes, heart block, or bradycardia
Angiotensin receptor blockers
Antidepressants
- Amitriptyline (30-150 mg/day) 1
Antiepileptic drugs
- Topiramate (100 mg/day)
- Divalproex sodium (500-1500 mg/day) 1
Non-Pharmacological Approaches
These approaches are particularly valuable for patients with contraindications to multiple medication classes:
Behavioral interventions
- Cognitive-behavioral therapy (CBT)
- Biofeedback
- Regular sleep schedule
- Stress management 1
Physical interventions
- Regular aerobic exercise (as effective as some medications) 1
Supplements
- Oral magnesium (400-600 mg daily) - most evidence-supported supplement 1
Important Clinical Considerations
Medication overuse: Using acute medications more than 10-15 days/month can perpetuate headaches 1, 3
Special populations: Women with migraine with aura have higher stroke risk and require special consideration regarding hormonal therapies 1
Monitoring: Maintain a headache diary to track frequency, intensity, duration, medication use, and potential triggers 1
Referral criteria: Consider specialist referral after failure of two or more preventive medication trials, uncertain diagnosis, or complex comorbidities 1